ABCLAbCellera Biologics Inc.vs its industry peers
A metric-by-metric comparison of AbCellera Biologics Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABCLEsta | $3.8B#6 | — | 4.2x#4 | 50.0x#4 | 160.6%#2 | 10.1%#4 | -289.0%#4 | -16.3%#5 | -28.0%#2 | — | 128.6%#1 | — |
| TVTX | $4.6B#1 | — | 203.9x#8 | 9.4x#2 | 110.5%#3 | 92.1%#1 | -12.8%#2 | -113.1%#8 | — | — | — | — |
| GOSS | $4.4B#2 | — | — | 91.3x#5 | -57.7%#5 | -201.4%#7 | -352.2%#5 | — | — | — | — | — |
| GPCR | $4.4B#3 | — | 3.2x#2 | — | — | -15.2%#5 | — | -10.4%#4 | — | — | — | — |
| EWTX | $4.2B#4 | — | 9.3x#6 | — | — | -25.4%#6 | — | -0.0%#3 | -50.9%#3 | — | 112.7%#2 | — |
| LQDA | $3.8B#5 | 30.1x#2 | 19.3x#7 | 23.8x#3 | 1031.2%#1 | 47.1%#3 | -32.5%#3 | -35.3%#6 | — | — | 66.8%#3 | — |
| PBLS | $3.6B#7 | — | 3.4x#3 | — | — | — | — | 0.0%#2 | — | — | — | — |
| ACAD | $3.6B#8 | 9.3x#1 | 2.7x#1 | 3.3x#1 | 11.9%#4 | 73.0%#2 | 9.8%#1 | 29.9%#1 | 11.4%#1 | — | — | — |
| VKTX | $3.4B#9 | — | 5.8x#5 | — | — | -227.1%#8 | — | -61.1%#7 | — | — | -26.0%#4 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice